// Biotech and Pharma Therapeutics
Beyond the Basics: 3 Ways to Win with Your Mobile Health Strategy
June 11, 2025 / mobile health strategy / patient engagement technology / personalized healthcare apps / digital patient journey / unified health system platform
Healthcare mobile strategies must prioritize unified, personalized, and convenient digital experiences that eliminate friction in the patient journey, driving better engagement, brand loyalty, and improved clinical access through seamless integration of scheduling, navigation, and communication tools.
MetroHealth and MUSC Health make for a patient engagement powerhouse
June 11, 2025 / virtual-first care / digital health platform / patient engagement strategy / Epic EHR integration / personalized healthcare app
MetroHealth and MUSC Health have launched MyCare Anywhere, a unified, EHR-integrated digital health platform delivering personalized virtual care, education, and engagement. Built on Epic, it consolidates patient tools, improving access, navigation, and outcomes across the care continuum.
Pharmas to face higher drug rebates in UK despite government’s tweak to proposal
June 11, 2025 / UK drug rebate 2025 / MASH treatment funding / branded medicine pricing / pharmaceutical R&D UK / NHS drug spending cap
The U.K. government will impose a 31.3% drug rebate on branded medicines for H2 2025—up significantly from prior years—despite industry pushback. Pharma leaders warn this could hinder R&D investment and U.K. competitiveness in global drug innovation.
7 Ways AI Is Helping Nurses and Transforming Healthcare
June 11, 2025 / AI in nursing / nurse burnout solutions / predictive analytics healthcare / clinical decision support AI / healthcare administrative automation
AI-powered tools are helping nurses by reducing administrative burdens, supporting clinical decisions, and improving patient care through predictive analytics, task prioritization, and communication support—potentially alleviating burnout and enhancing care quality amid a global nursing shortage.
Argenx presents new efgartigimod data at EULAR 2025
June 11, 2025 / efgartigimod / myositis treatment / Sjogren’s disease therapy / FcRn inhibitor / Argenx clinical trials
Argenx presented promising phase 2 data showing efgartigimod significantly improves outcomes in myositis and Sjogren’s disease, with rapid, sustained benefits and a favorable safety profile. The FDA granted Fast Track designation for primary Sjogren’s; phase 3 trials continue.
// 4th Industrial Revolution
Zorro Secures $20M for AI-Powered Benefits Adminstration Platform
June 11, 2025 / AI healthcare platform / ICHRA benefits / personalized health insurance / Zorro benefits platform / health plan cost savings
Zorro raised $20M to expand its AI-powered platform that enables employers to replace traditional group health plans with personalized, cost-efficient ICHRAs. The platform supports data-driven plan selection, reducing costs while improving healthcare coverage personalization.
Humata Health’s AI-Powered Prior Authorization Platform Now Available on Microsoft Azure Marketplace
June 11, 2025 / AI prior authorization / healthcare automation / Humata Health Azure / payer provider platform / Microsoft healthcare solutions
Humata Health’s AI-driven platform for automating prior authorizations is now available on Microsoft Azure Marketplace, enabling streamlined deployment for healthcare providers and payers to accelerate approvals, reduce administrative burden, and improve patient access to timely care.
Mayo Clinic launches new AI-assisted virtual care collaboration
June 11, 2025 / Mayo Clinic / virtual care / ambient intelligence / smart hospital
Mayo Clinic Florida partners with Hellocare.ai to implement AI-powered virtual care and ambient clinical intelligence, aiming to reduce hospitalizations, enhance patient outcomes, and create smarter, more connected healthcare environments.
A symbiosis observed: How AI is refining the savviness of the e-patient
June 10, 2025 / AI healthcare / e-patient empowerment / digital health / clinical reasoning
AI is reshaping healthcare by enhancing e-patient empowerment through clinical reasoning tools, improved access to information, and data-driven self-care—while also raising critical ethical concerns around safety, equity, and digital governance.
Using causal machine learning to identify potential ALS treatments
June 10, 2025 / ALS treatment / drug repurposing / causal learning / neurodegenerative disease
Researchers are using causal machine learning and EHR data to identify existing drugs that may slow ALS progression. Statins, alpha-blockers, and PDE5-inhibitors emerged as promising candidates, offering potential faster treatment pathways through drug repurposing.
// Business & Markets
The ROI of Online Patient Payments is Significant
June 11, 2025 / digital health payments / patient billing automation / healthcare revenue cycle / online patient payments / EHR integration
First Choice Neurology improved cash flow, reduced administrative burden, and enhanced patient satisfaction by implementing digital payment tools. Transitioning to mobile-first billing cut costs by up to $10K/month and accelerated revenue collection by reducing days in AR.
The Future of Mobility: Wandercraft Raises $75M for Self-Balancing Exoskeletons
June 11, 2025 / robotic rehabilitation exoskeleton / stroke recovery technology / AI mobility innovation / personal mobility device / neurological rehabilitation robotics
Wandercraft raised $75M to expand its self-balancing exoskeleton technology, including the Atalante X for stroke rehabilitation and the upcoming Eve personal exoskeleton. These AI-powered systems enhance mobility and independence for individuals with neurological and musculoskeletal impairments.
Blue Shield of California and Zocdoc to Streamline In-Network Appointment Booking
June 11, 2025 / digital health access / patient appointment booking / in-network provider scheduling / healthcare navigation tools / virtual care integration
Blue Shield of California partnered with Zocdoc to integrate real-time in-network appointment scheduling into its member portal, streamlining access to both in-person and virtual care and aiming to reduce delays and improve healthcare engagement.
VA takes steps to eliminate 80K jobs, says report
June 11, 2025 / veterans healthcare workforce / VA job cuts 2025 / federal healthcare layoffs / VA IT infrastructure risk / patient data security
The U.S. Department of Veterans Affairs is planning to eliminate up to 80,000 jobs, raising concerns about the impact on veteran care, IT infrastructure, and data security. Lawmakers are pressing for oversight and transparency in the reorganization process.
HHS reverses hundreds of CDC firings
June 11, 2025 / CDC staff reinstatement / HHS reorganization 2025 / public health workforce / CDC global health cuts / STI prevention funding
HHS has reversed the termination of over 450 CDC staff involved in critical public health areas like STI prevention, global health, and cruise ship safety, amid a broader reorganization that significantly downsized federal health agencies.
// Legal & Regulatory
Capital Rx Expands Into Care Navigation with Acquisition of Amino Health
June 11, 2025 / Capital Rx acquisition / care navigation platform / Amino Health merger / pharmacy benefit management / digital health benefits
Capital Rx has acquired Amino Health to launch Judi Care, an integrated care navigation platform that helps health plan members manage benefits, assess provider quality, and schedule care—expanding services to over 60 million covered lives.
FDA clears Nuvation lung cancer drug, setting up battle with Bristol Myers and Roche
June 11, 2025 / FDA clears Nuvation lung cancer drug, setting up battle with Bristol Myers and Roche
The FDA has approved Nuvation Bio’s Ibtrozi for ROS1-positive metastatic non-small cell lung cancer, showing strong response rates up to 90% in treatment-naïve patients. Side effects included liver toxicity and cardiac risks; 7% discontinued therapy.
FDA schedules first public MDUFA VI meeting ahead of negotiations
June 11, 2025 / FDA MDUFA VI meeting / medical device user fees / FDA device fee reform / user fee reauthorization 2023–2027 / FDA public meeting August 2025
The FDA will hold a public meeting on August 4 to gather input on potential changes to the Medical Device User Fee Amendments (MDUFA VI), including fee structure revisions and program effectiveness for the 2023–2027 cycle.
FDA aims for ‘rapid or instant’ drug reviews, with AI tool initially assessing applications
June 11, 2025 / FDA AI drug review / generative AI Elsa / accelerated FDA approvals / AI in regulatory science / FDA review process reform
The FDA is integrating AI, including its new tool Elsa, to expedite drug reviews by performing initial evaluations of large application files. The agency aims to pilot programs delivering decisions within weeks, emphasizing pre-trial data submission and review acceleration.
URGN Investors Have Opportunity to Lead UroGen Pharma Ltd. Securities Fraud Lawsuit
June 10, 2025 / UroGen lawsuit 2025 / UGN-102 FDA trial / securities fraud pharma / bladder cancer drug trial / UroGen clinical study
UroGen Pharma faces a securities fraud lawsuit alleging it misled investors about the clinical design and regulatory viability of UGN-102, its bladder cancer treatment. Claims include flawed trial design and non-compliance with FDA guidance, risking approval prospects.
// Research & Development
Unusual carbon build-up found in lungs of COPD patients
June 10, 2025 / COPD inflammation / alveolar macrophages carbon / lung soot deposits / air pollution lung disease / COPD carbon accumulation
COPD patients show over three times more carbon accumulation in lung immune cells than smokers without COPD, potentially driving inflammation and impaired lung function. This carbon build-up may stem from reduced clearance or higher particulate exposure.
Unraveling mitochondrial influence on mammalian pluripotency via enforced mitophagy
June 10, 2025 / mitochondrial DNA pluripotency / enforced mitophagy stem cells / interspecies PSC fusion / mitochondrial function development / mitochondrial-nuclear compatibility
Researchers used enforced mitophagy to deplete mitochondria from pluripotent stem cells, showing survival without mitochondria and enabling interspecies mitochondrial DNA studies. Findings reveal mitochondrial-nuclear compatibility and highlight mitochondria’s critical, species-specific roles in development and cellular function.
New 3D model reveals hidden role of stem cells in sense of smell
June 11, 2025 / stem cell regeneration / olfactory neuron repair / 3D organoid model / age-related smell loss / horizontal basal cells
A new 3D olfactory tissue model reveals that previously overlooked horizontal basal stem cells (HBCs) actively support neuron regeneration in the nose, offering insights into age-related smell loss and recovery mechanisms following infection or environmental damage.
Scientists discover natural cancer-fighting sugar in sea cucumbers
June 11, 2025 / cancer enzyme inhibition / sea cucumber compound / Sulf-2 blocker therapy / marine-based cancer treatment / fucosylated chondroitin sulfate
A sugar compound from sea cucumbers blocks Sulf-2, an enzyme linked to cancer progression, without affecting blood clotting. This marine-derived molecule offers promise for safer, more effective cancer therapies through targeted enzyme inhibition and potential synthetic development.
Women, young adults, and Native people hit hard by rapid increase in alcohol liver deaths, study finds
June 11, 2025 / alcohol liver disease / liver death rates / women liver health / Indigenous health disparities / young adult liver inflammation
Alcohol-related liver disease deaths have surged nearly 9% annually since 2018, with sharp increases among women, young adults, and Indigenous populations. The trend worsened during the pandemic, highlighting a growing public health crisis in liver-related mortality.
// Politics
Former, current CDC employees call on RFK Jr. to resign
June 10, 2025 / CDC funding cuts / RFK Jr. resignation / public health workforce / disease outbreak preparedness / healthcare protest movement
Former and current CDC staff are urging Health Secretary RFK Jr. to resign, citing that deep staffing and funding cuts threaten the agency’s ability to manage future public health crises and safeguard national health infrastructure.
RFK Jr. names new members of CDC’s vaccine advisory panel
June 11, 2025 / CDC vaccine panel / RFK Jr. appointments / vaccine policy controversy / immunization advisory committee / vaccine safety concerns
Health Secretary RFK Jr. appointed eight new members to the CDC’s vaccine advisory panel, including individuals with limited immunization expertise and known vaccine skepticism—raising concern among experts about the credibility and scientific rigor of future vaccine policy guidance.
Trump says tariff deal with China is ‘done’
June 11, 2025 / pharmaceutical supply chain / rare earth elements / U.S.–China trade deal / healthcare manufacturing costs / medical technology imports
While not directly healthcare-related, the U.S.–China tariff deal may impact the pharmaceutical supply chain by influencing the cost and availability of medical components, including rare earth elements used in diagnostics and imaging technologies.
Pharma’s wins and losses in the budget bill
June 11, 2025 / Medicare drug pricing / PBM reform legislation / orphan drug exemption / pill penalty fix / Inflation Reduction Act
The current budget bill proposes reforms to Medicare drug pricing and pharmacy benefit managers, including expanded orphan drug exemptions and a ban on PBM spread pricing. However, key small molecule drug protections, like the “pill penalty” fix, remain absent.
Firing of CDC’s vaccine advisers puts spotlight on RFK Jr.’s promises to Cassidy
June 10, 2025 / CDC vaccine panel / Robert F. Kennedy Jr. / vaccine policy shift / Bill Cassidy confirmation / public health advisory
Health Secretary Robert F. Kennedy Jr.’s removal of CDC vaccine advisers raises concerns about politicizing vaccine policy. The move contradicts prior reassurances made to Senator Bill Cassidy, a physician, during Kennedy’s confirmation process.